<?xml version="1.0" encoding="UTF-8"?>
<p>Eczema or atopic dermatitis has become one of the most common skin problems globally.
 <sup>
  <xref rid="bibr1-1559325820956798" ref-type="bibr">1</xref>
 </sup> The prolonged involvement of the patients in atopic dermatitis disturbs the quality of life significantly, creates economic and social setbacks in families.
 <sup>
  <xref rid="bibr2-1559325820956798" ref-type="bibr">2</xref>,
  <xref rid="bibr3-1559325820956798" ref-type="bibr">3</xref>
 </sup> According to the WHO Global Burden of Diseases, 230 million people have atopic dermatitis with 3.5% global annual period prevalence.
 <sup>
  <xref rid="bibr4-1559325820956798" ref-type="bibr">4</xref>
 </sup> Many countries have lifetime prevalence of even more than 15%,
 <sup>
  <xref rid="bibr5-1559325820956798" ref-type="bibr">5</xref>
 </sup> 10-25% in children, and 2-8% in adults. Among them, 25% of the victims have moderate to severe illness.
 <sup>
  <xref rid="bibr6-1559325820956798" ref-type="bibr">6</xref>,
  <xref rid="bibr7-1559325820956798" ref-type="bibr">7</xref>
 </sup> Annual cost for the treatment of the atopic dermatitis in United States is approximately $5.297.
 <sup>
  <xref rid="bibr8-1559325820956798" ref-type="bibr">8</xref>
 </sup>
</p>
